
|Articles|October 28, 2019
Comparative human in-vivo study of an immediate release tablet over-encapsulated by gelatin and HPMC capsules
Author(s)Capsugel® Ι Lonza Pharma & Biotech
In this executive summary, experts will present the in vitro dissolution and an in vivo bioequivalence study comparing the performance of the identical formulation of three different drugs in Capsugel® Vcaps® Plus capsules to hard gelatin capsules. In addition, the circumstances under which the same API and formulation contained in HGC and Capsugel® Vcaps® Plus can be expected to provide equivalent performance will be discussed.
Trending on Pharmaceutical Technology
1
European Biotechs Reshaping Respiratory Disease
2
Midyear 2026 Industry Report: Taking Stock of Pharma Manufacturing, AI, and Regulatory Trends
3
GSK Cambridge Move Signals Shift in Drug Scale-Up Strategy
4
Six Months In: A 2026 Progress Check on Pharma Manufacturing, AI, and Regulatory Shifts
5